LI-F antibiotics, a family of antifungal cyclic depsipeptides produced by Bacillus polymyxa L-1129

Heterocycles

Volumn 53, Issue 7, 2000, Pages 1533-1549

  Kuroda, Jun ^a   Fukai, Toshio ^a   Konishi, Masataka ^a   Ono, Jun ^b   Kurusu, Keiji ^c   Nomura, Taro ^a  

^a TOHO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c LION CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIFUNGAL AGENT; CYCLODEPSIPEPTIDE; DEXTRO ALANINE; LIF 03A; LIF 03B; LIF 04A; LIF 04B; LIF 05A; LIF 05B; LIF 06A; LIF 06B; LIF 07A; LIF 07B; LIF 08A; LIF 08B; THREONINE;

AMINO ACID ANALYSIS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS POLYMYXA; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION;

EID: 0034234857     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-00-8922     Document Type: Article

References (28)

1. H. F. Chambers and M. A. Sande, 'Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., ed. by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, McGraw-Hill, New York, 1996, pp. 1029-1056;
2. (b) J. E. Bennett, ibid., pp. 1175-1190.
3. E. Mutschler, H. Derendorf, M. Schäfer-Korting, K. Elrod, and K. S. Ester, 'Drug Action: Basic Principles and Therapeutic Aspects,' medpharm Scientific Publisher, Stuttgart, 1995, pp. 70-79, 559-564.
4. G. F. Brooks, J. S. Butel, S. A. Morse, R. Nairm, T. G. Mitchell, and D. Heyneman, 'Jawetz, Melnick, & Adelberg's Medical Microbiology, 21st ed.,' Appleton & Lange, Stamford, 1998, pp. 1-6, 583-616.
5. E. Eberle, 'Iryo-jujisha no tameno AIDS (in Japanese, The AIDS for the medical Workers)', ed. by J. Tadano, M. Sano, and E. Inoue, Nanzan-do, Tokyo, 1995, pp. 17-56.
6. Authority of the United States Pharmacopeial Convention Inc., 'Advice for the Patient, Drug Information in lay language, Vol. II', U.S. Pharmacopeial Convention Inc., Rockville, 1992, pp. 74-77.
7. K. Kurusu, K. Ohba, T. Arai, and K. Fukushima, J. Antibiotics, 1987, 40, 1506.
8. J. Uno, unpublished data.
9. J. Uno, M. L. Shigematsu, and T. Arai, Antimicrob. Agents Chemother., 1983, 24, 552.
10. J. Uno, Jpn. J. Med. Mycol., 1985, 26, 133.
11. K. Takesako, T. Beppu, T. Nakamura, and A. Obayashi, J. Antibiotics, 1985, 38, 1363.
12. K. Kajimura and M. Kaneda, J. Antibiotics, 1996, 49, 129.
13. K. Kajimura and M. Kaneda, J. Antibiotics, 1997, 50, 220.
14. Y. Takayama, S. Yamada, M. Yamanaka, T. Koyama, T. Mori, M. Ozawa, and H. Asami, (Mitsubishi Petrochemical Co., Ltd.), Jpn. Kokai Tokkyo Koho 1990, JP 02275898 A2, (Chem. Abstr., 1991, 115, 66784).
15. T. Fukai, J. Kuroda, and T. Nomura, J. Am. Soc. Mass Spectrom., 2000, 11, 458.
16. 16 The details of the weak fragment ion peaks of the ESI-MS will be report elsewhere.
17. M. Takayama and A. Tsugita, Int. J. Mass Spectrom. Ion Processes 1998, 181, L1 and references cited therein.
18. Roepstorff, Biomed. Mass Spectrom., 1984, 11, 601;
19. K. Biemann, Biomed. Environ. Mass Spectrom., 1988, 16, 99;
20. R. S. Johnson, S. A. Martin, and K. Biemann, Int. J. Mass Spectrom. Ion Processes, 1988, 86, 137.
21. +.
22. V. Kasche and G. Michaelis, 'Biochemistry of Peptide Antibiotics: recent advances in the biotechnology of β-lactams and microbial bioactive peptides', ed. by H. Kleinkauf and K. von Döhren, de Gruyter, Berlin, 1990, pp. 81-101; H. G. Fliri and R. M. Wenger, ibid., pp. 245-287; Y. Okumura, ibid., pp. 365-378; E. J. Vandamme, ibid., pp. 379-410.
23. V. Kasche and G. Michaelis, 'Biochemistry of Peptide Antibiotics: recent advances in the biotechnology of β-lactams and microbial bioactive peptides', ed. by H. Kleinkauf and K. von Döhren, de Gruyter, Berlin, 1990, pp. 81-101; H. G. Fliri and R. M. Wenger, ibid., pp. 245-287; Y. Okumura, ibid., pp. 365-378; E. J. Vandamme, ibid., pp. 379-410.
24. V. Kasche and G. Michaelis, 'Biochemistry of Peptide Antibiotics: recent advances in the biotechnology of β-lactams and microbial bioactive peptides', ed. by H. Kleinkauf and K. von Döhren, de Gruyter, Berlin, 1990, pp. 81-101; H. G. Fliri and R. M. Wenger, ibid., pp. 245-287; Y. Okumura, ibid., pp. 365-378; E. J. Vandamme, ibid., pp. 379-410.
25. V. Kasche and G. Michaelis, 'Biochemistry of Peptide Antibiotics: recent advances in the biotechnology of β-lactams and microbial bioactive peptides', ed. by H. Kleinkauf and K. von Döhren, de Gruyter, Berlin, 1990, pp. 81-101; H. G. Fliri and R. M. Wenger, ibid., pp. 245-287; Y. Okumura, ibid., pp. 365-378; E. J. Vandamme, ibid., pp. 379-410.
26. Y. Kyogoku and K. Kawano, 'Protein, Nucleic Acid and Enzyme, Separate volume (in Japanese), 76:5," ed. by H. Umezawa, T. Shiba, and T. Takida, Kyoritu-Shuppan, Tokyo, 1976, pp. 281-298.
27. T. Fukai, J. Kuroda, M. Konishi, T. Nomura, N. Naruse, and R. Isobe, J. Antibiotics, 1995, 48, 1115.
28. National Committee for Clinical Laboratory Standards, 1997. Reference method for broth dilution antifungal susceptibility testing for yeasts: proposed standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.